News
AstraZeneca CEO Pascal Soriot said the U.K.-listed company had many reasons to be in the U.S., adding that it was “rapidly ...
AstraZeneca’s chief executive has said the drugmaker is a “very American company” amid growing speculation it will shift its ...
AstraZeneca Plc reported better-than-expected sales and rising profit for the second quarter, spurred by its stable of cancer ...
AstraZeneca share price held steady this week after the company published strong financial results on Tuesday.
AstraZeneca shares are rising in premarket trading Tuesday after the pharma giant beat second-quarter estimates on strong U.S ...
AstraZeneca has dropped the lead candidate from its $200 million buyout of Neogene Therapeutics as part of a wider cell ...
AstraZeneca on Tuesday beat second-quarter revenue and profit expectations on robust sales of newer cancer, heart and kidney ...
AstraZeneca (NASDAQ:AZN) has announced an interim dividend of $1.03/share. The record date for the first interim dividend for 2025, payable on September 8, 2024, will be August ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback